SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
PRER14A

Proxy soliciting materials. Revised preliminary material

Proxy Filings
View HTML
UPLOAD

UPLOAD

Other
View HTML
CT ORDER

CT ORDER

Other
View HTML
S-3/A

Pre-effective amendment to an S-3 filing

Registration Statements
View HTML
S-3

Simplified registration form

Registration Statements
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe